Taiwan FDA registration f7eae2ff0a240cd64490c75d0e7b41c3
“Ortho” Anti-Fyb (FY2)
TW: “奧素” 抗Fyb血清
Taiwan·Risk Class 2·MD·ORTHO-CLINICAL DIAGNOSTICS, INC.·Registered Jun 21, 2016 – Jun 21, 2026ExpiredRegistration details
- Analysis ID
- f7eae2ff0a240cd64490c75d0e7b41c3
- License Form
- Ministry of Health Medical Device Import No. 028449
- Customs Code
- DHA05602844902
Company information
- Manufacturer
- ORTHO-CLINICAL DIAGNOSTICS, INC.
- Manufacturer Country
- United States
- Authorized Representative
- DKSH TAIWAN LTD.
Product details
- Intended Use
- Qualitative detection of Fyb antigen on human red blood cells.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B4020 Analyze specific reagents
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jun 21, 2016
- Expiry Date
- Jun 21, 2026
About this record
Access comprehensive regulatory information for “Ortho” Anti-Fyb (FY2) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f7eae2ff0a240cd64490c75d0e7b41c3 and manufactured by ORTHO-CLINICAL DIAGNOSTICS, INC.. The authorized representative in Taiwan is DKSH TAIWAN LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices